Skip to main content
. 2003 Oct 1;5(6):R347–R351. doi: 10.1186/ar1005

Figure 2.

Figure 2

Disease activity score (DAS) response/remission after 3–6 months therapy with etanercept with or without methotrexate (MTX). Data are the percentages of patients achieving the European League Against Rheumatism criteria for moderate/good clinical response and for remission.